HAI-1 expression in villous tissue of early gestational period in women

Journal of Sichuan University (Medical Science)

Volumn 37, Issue 4, 2006, Pages 602-605

  Fan, Cai Bo ^a   He, Jun Lin ^a   Wang, Ying Xiong ^a   Liu, Xue Qing ^a   Chen, Xue Mei ^a   Li, Hong Mei ^a   Ding, Yu Bin ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocyte growth factor activator inhibitor type 1(HAI 1); Immunohistochemistry; RT PCR; Villous

Indexed keywords

BETA ACTIN; CYTOKINE; HEPATOCYTE GROWTH FACTOR ACTIVATOR INHIBITOR TYPE 1; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CHORION VILLUS; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; GENE EXPRESSION; GESTATION PERIOD; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NIDATION; PREGNANCY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 33746620489     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Shimomura T, Denda K, Kitamura A, et al. Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor. J Biol Chem, 1997;272(10):6370-6376.
2. Kirchhofer D, Peek W, Li W, et al. Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1. J Biol Chem, 2003;278(38):36341-36349.
3. Tanaka H, Nagaike K, Takeda N, et al. Hepatocyte growth factor activator inhibitor type 1 (HAI-1) Is required for branching morphogenesis in the chorioallantoic placenta. Mol Cell Biol, 2005;25(13):5687-5698.
4. Itoh H, Kataoka H. Roles of hepatocyte growth factor activator (HGFA) and its inhibitor HAI-1 in the regeneration of injured gastrointestinal mucosa. J Gastroenterol, 2002;37 (Suppl 14):15-21.
5. Denda K, Shimomura T, Kawaguchi T, et al. Functional characterization of Kunitz domains in hepatocyte growth factor activator inhibitor type 1. J Biol Chem, 2002;277(16):14053-14059.
6. Parr C, Watkins G, Mansel RE, et al. The hepatocyte growth factor regulatory factors in human breast cancer. Clin Cancer Res, 2004;10(1 Pt 1):202-211.
7. Oberst MD, Anders J, Xie B, et al. Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo. Am J Pathol, 2001;158(4):1301-1311.
8. Oberst MD, Chen LY, Kiyomiya KI, et al. HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease. Am J Physiol Cell Physiol, 2005;289(2):C462-470.
9. Kataoka H, Hamasuna R, Itoh H, et al. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma. Cancer Res, 2000;60(21):6148- 6159.
10. Yamauchi M, Kataoka H, Itoh H, et al. Hepatocyte Growth Factor activator inhibitor types 1 and 2 are expressed by tubular epithelium in kidney and down-regulated in renal cell carcinoma. J Urol, 2004;171(2):890-896.
11. Itoh H, Naganuma S, Takeda N, et al. Regeneration of injured intestinal mucosa is impaired in hepatocyte growth factor activator-deficient mice. Gastroenterology, 2004;127 (5):1423-1435.
12. List K, Haudenschild CC, Szabo R, et al. Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis. Oncogene, 2002;21(23):3765-3779.